Pressly Ahammed, Director International Business Development at INVO Bioscience, Inc. (IVOB)
- Nov 13, 2019
By
[social_share_button themes='theme8']
Pressly Ahammed
Director International Business Development at INVO Bioscience, Inc. (IVOB)
“We are extremely pleased to have established commercialization agreements with Orcan Medical and Biovate to expand our reach into the Eurasian market. Infertility is an issue throughout the entire world. Unfortunately, due to the high cost and limited access of existing treatments, many go without treatment. We believe the INVOcell solution solves these important issues and we look forward to working with the teams at Orcan and Biovate to bring our technology to the people of Turkey and Jordan.”
You Might Also Like
Stay Informed. Stay Competitive.
Vista Partners offers an exclusive newsletter and content with daily, weekly, monthly and quarterly investing ideas, strategies, and marketing insights.
We value your privacy and will never share your information.
Recent Posts
VP Watchlist
Trending Posts
-
AI Firm Lantern Pharma Receives Regulatory Approval to...
-
Indaptus Therapeutics’ Decoy Platform Successfully Induces, Matures or...
-
VISTA ALERT: InMed Reports ‘Triple Digit’ Revenue Growth...
-
Did NVIDIA’s $50M Investment In Recursion Just Open...
-
Artificial Intelligence Co., Lantern, Data Published Demonstrating Antitumor...